Vista Pharmaceuticals Share Price

BSE
10.69
-0.43 (9.52%)
VISTAPH • 18 Jun, 2025 | 03:30 PM
BUY

1Y Annualised Return

-17.69%

3Y Annualised Return

15.09%

5Y Annualised Return

0.77%

The current prices are delayed, login or Open Demat Account for live prices.

Vista Pharmaceuticals SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹59,55,327 (-8.38%)

Daily SIP of 25,000 would have become 59,55,327 in 1 year with a gain of -5,44,672 (-8.38%)

Vista Pharmaceuticals Stock Performance
Today’s Low - High
10.57
10.95
10.57
10.95
52 Week Low - High
9.10
16.59
9.10
16.59

Open

10.64

Prev. Close

11.12

Volume

77,693.00

Total Traded Value

8.31 L

View details of Market Depth
Vista Pharmaceuticals Fundamental

Market Cap (in crs)

65.80

Face Value

2

Turnover (in lacs)

8.31

Key Metrics
Qtr Change %
35.56% Fall from 52W High
-2.8
Dividend yield 1yr %
0

Vista Pharmaceuticals shareholding Pattern

Promoter
21.2%
Public
78.8%
Promoter
21.2%
Public
78.8%
Promoter
21.2%
Public
78.8%
Promoter
21.2%
Public
78.8%
Promoter
27.8%
Public
72.2%
Promoter
27.8%
Public
72.2%

Vista Pharmaceuticals Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
10.69
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
11.10
10Day EMA
11.20
12Day EMA
11.20
20Day EMA
11.10
26Day EMA
11.10
50Day EMA
11.00
100Day EMA
11.10
200Day EMA
11.60
5Day SMA
11.20
10Day SMA
11.30
20Day SMA
11.00
30Day SMA
10.90
50Day SMA
11.10
100Day SMA
10.80
150Day SMA
11.10
200Day SMA
11.50
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
60488 Rs
77693 Rs
Week Rs
16105 Rs
20005 Rs
Month Rs
7420 Rs
8306 Rs
Resistance & Support
10.74
Pivot
Resistance
First Resistance
10.90
Second Resistance
11.12
Third Resistance
11.28
Support
First Support
10.52
Second support
10.36
Third Support
10.14
Relative Strength Index
45.09
Money Flow Index
19.15
MACD
0.08
MACD Signal
0.08
Average True Range
0.67
Average Directional Index
10.67
Rate of Change (21)
-2.82
Rate of Change (125)
-7.92

Vista Pharmaceuticals Latest News

30 MAY 2025 | Friday

Vista Pharmaceuticals Ltd - 524711 - Compliances-Reg.24(A)-Annual Secretarial Compliance

30 MAY 2025 | Friday

Vista Pharmaceuticals Ltd - 524711 - Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

20 MAY 2025 | Tuesday

Vista Pharmaceuticals Ltd - 524711 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2025

View More

Vista Pharmaceuticals Company background

Founded in: 1991
Managing director: Murali Meraga
Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh has obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and antiinfection, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India.The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets 200 million capsules per annum. Apart from these, the Company offers over the counter prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market of expanding Globally. It is the first Indian Company to obtain USFDA Approvals to produce OTC as well as Prescription Drugs to US Market in 1994. It is the first Indian Company to export OTC as well as Prescription Drugs to US in 1996. The Companys Indian Facility got USFDA Approval in June 2010 to produce ANDA products to US Market. It established an extensive Marketing and Distribution Network in the United States. The Company operations are going on as per USFDA cGMP norms. The validations and stability testing studies are going on as per schedules. Its stateoftheart Facility in India is built according to cGMP and USFDA standards.

As of 18 Jun, 2025, Vista Pharmaceuticals share price is ₹10.7. The stock opened at ₹10.6 and had closed at ₹11.1 the previous day. During today’s trading session, Vista Pharmaceuticals share price moved between ₹10.57 and ₹10.95, with an average price for the day of ₹10.00. Over the last 52 weeks, the stock has recorded a low of ₹9.10 and a high of ₹16.59. In terms of performance, Vista Pharmaceuticals share price has declined by 9.4% over the past six months and has declined by 17.69% over the last year.

Read More

Vista Pharmaceuticals FAQs

The Mutual Fund Shareholding in Vista Pharmaceuticals was 0.02% at the end of 18/6/2025.

You can easily buy Vista Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Vista Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -